PPT-COVID-19 (disease) SARS-CoV-2

virus Guam Department of Public Health and Social Services Disclaimer This is a rapidly evolving situation Information and guidance are constantly changing Information presented in these slides may already be outofdate. CTropMed. 3/17/20. COVID-19. SARS-CoV-2. 2019-nCov. HCoV-19. Disease. Virus Name. 7 Human Coronaviruses:. 4 normal; 3 “novel”. Alpha: . HCoV-229E. , . HCoV-NL63 . Beta: . HCoV-HKU1. , . HCoV-OC43. Page 9 Yan Leyfman 1 , Timothy K. Erick 1 , Pushpa Sharma 1,2 1 WACEM-ACAIM Joint Global COVID-19 Taskforce— Immunology Division, USA 2 Department of Anaesthesiology, Uniformed Services Universit January 2 7 , 202 1 Page | 1 d for Standar Final 220, - 16VAC25 Infectious Disease Prevention of the SARS - CoV - 2 Virus That Causes COVID - 19 As Adopted by the Safety and Health Codes Board on January 272021Page 1d forStandarFinal 220 -16VAC25Infectious Disease Preventionofthe SARS-CoV-2 Virus That Causes COVID-19As Adopted by theSafety and Health Codes Boardon January 13 2021VIRGINIA OCCU One Health Partners Monthly COVID-19 WebinarCoordinated by the CDCOne Health Office in partnership with the One Health Federal Interagency COVID-19 Coordination OH-FICC GroupOne SARS-CoV-Updated 3/2/2020Samuel R Dominguez MD PhD and Ann-Christine Nyquist MD MSPH1What is the SARS-CoV-2and where did it come fromSARS-CoV-2 previously called 2019 novel coronavirusis a coronavirus The more the virus circulates, the more the virus will evolve
Most changes have little to no impact on the virus’s properties or behaviour
However, some changes to SARS-CoV-2 lead to the emergence of variants that may affect: Andreas J . Deymann. , MD. Chair of the Department of Pediatrics . Memorial Hospital South Bend. Justin Chow, MD, FACP, . FHM. Hospitalist. Director . of Mid-Level Program of Hospitalist Department. Memorial Hospital South Bend. 2019). PRESENTED BY. Image: . “Coronaviruses viewed under an electron microscope. Note the characteristic crown-like (corona) appearance” . By CDC/Dr. Fred Murphy. ETIOLOGY. Coronaviruses (. CoV. David J. Weber, MD, MPH, FIDSA, FSHEA, FRSM (London). Sanders Distinguished Professor of Medicine, Pediatrics and Epidemiology. Associate Chief Medical Officer. Medical Director, Hospital Epidemiology. *AddresscorrespondencetoGowriKaruppasamy,InternalMedicineDepartment,HamadMedicalCorporation,AlRayyanRoad,POBox3050,Doha,Qatar.E-mail:gkaruppasamy@hamad.qa cantinvestigationsincludedlipaseof�1,2 Constance A. Benson, MD. Professor of Medicine and Global Public Health. University of California San Diego. La Jolla, California. Financial Relationships With Commercial Entities. Dr Benson has served on advisory and data safety monitoring boards for GlaxoSmithKline/ViiV Healthcare, received research grants awarded to her institution from Gilead Sciences, Inc., and serves as a consultant to NDA Partners, LLC. Her spouse has served as a consultant to . Monica Gandhi, MD, MPH. Professor of Medicine . University of California San Francisco. San Francisco, California. What’s Known about the Intersection of COVID-19 and HIV Infection. Monica Gandhi MD, MPH. Menso. Westerouen van . Meeteren. and Joost PH . Drenth. . Radboud. UMC. , Nijmegen, The Netherlands . LIVER CO-MORBIDITIES AND COVID-19. Content. MAFLD and risk of . SARS-CoV-2. . transmission.